ABBV Stock Chart & Stats
C$34.62
-C$0.13(-0.37%)
―
--
Day’s Range― - ―
52-Week RangeC$26.89 - C$37.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
C$625.86B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)12.4
Beta0.41
Next Earnings
Jul 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.53
Shares Outstanding1,766,792,800
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ABBV FAQ
What was AbbVie, Inc. CDR (CAD Hedged)’s price range in the past 12 months?
AbbVie, Inc. CDR (CAD Hedged) lowest stock price was C$26.89 and its highest was C$37.00 in the past 12 months.
What is AbbVie, Inc. CDR (CAD Hedged)’s market cap?
AbbVie, Inc. CDR (CAD Hedged)’s market cap is C$625.86B.
When is AbbVie, Inc. CDR (CAD Hedged)’s upcoming earnings report date?
AbbVie, Inc. CDR (CAD Hedged)’s upcoming earnings report date is Jul 31, 2026 which is in 20 days.
How were AbbVie, Inc. CDR (CAD Hedged)’s earnings last quarter?
AbbVie, Inc. CDR (CAD Hedged) released its earnings results on Apr 29, 2026. The company reported C$0.53 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.53.
Is AbbVie, Inc. CDR (CAD Hedged) overvalued?
According to Wall Street analysts AbbVie, Inc. CDR (CAD Hedged)’s price is currently Undervalued.
Does AbbVie, Inc. CDR (CAD Hedged) pay dividends?
AbbVie, Inc. CDR (CAD Hedged) does not currently pay dividends.
What is AbbVie, Inc. CDR (CAD Hedged)’s EPS estimate?
AbbVie, Inc. CDR (CAD Hedged)’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AbbVie, Inc. CDR (CAD Hedged) have?
AbbVie, Inc. CDR (CAD Hedged) has 1,766,792,800 shares outstanding.
What happened to AbbVie, Inc. CDR (CAD Hedged)’s price movement after its last earnings report?
AbbVie, Inc. CDR (CAD Hedged) reported an EPS of C$0.53 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.248%.
Which hedge fund is a major shareholder of AbbVie, Inc. CDR (CAD Hedged)?
Currently, no hedge funds are holding shares in TSE:ABBV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AbbVie, Inc. CDR (CAD Hedged) Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-2.82%
Trailing 12-Months
Novartis AG CAD Hedged CIBC CDR
―
Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S
―
Johnson & Johnson Shs
―
Merck & Co., Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S
―
Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S
―









